This study assessed the prevalence of Aspergillus sensitisation in a well-characterised COPD cohort and its association with exacerbation frequency. Aspergillus sensitisation was identified in around 14% of patients and tended to be associated with a higher proportion of frequent exacerbators, despite similar lung function and eosinophil counts compared with non-sensitised patients. Although limited by small numbers, these findings suggest that Aspergillus sensitisation may contribute to exacerbation risk in COPD and support consideration of fungal screening in selected patients.
M28 How common is aspergillus sensitisation in COPD and is it related to frequent exacerbations?
Baraldi, F;
2024
Abstract
This study assessed the prevalence of Aspergillus sensitisation in a well-characterised COPD cohort and its association with exacerbation frequency. Aspergillus sensitisation was identified in around 14% of patients and tended to be associated with a higher proportion of frequent exacerbators, despite similar lung function and eosinophil counts compared with non-sensitised patients. Although limited by small numbers, these findings suggest that Aspergillus sensitisation may contribute to exacerbation risk in COPD and support consideration of fungal screening in selected patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
